Skip to main content
Log in

Genetics

Telomere length and the metabolic syndrome—a causal link?

  • News & Views
  • Published:

From Nature Reviews Endocrinology

View current issue Sign up to alerts

Shortening of leukocyte telomeres is considered a molecular marker for ageing and is suggested to be linked with increased risk of cardiovascular and metabolic disease. A large population-based study with 6 years of follow-up by Révész and colleagues reveals that short telomeres, at both baseline and during follow-up, are associated with an increased risk of metabolic abnormalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Tzanetakou, I. P., Nzietchueng, R., Perrea, D. N. & Benetos, A. Telomeres and their role in aging and longevity. Curr. Vasc. Pharmacol. 12, 726–734 (2014).

    Article  CAS  Google Scholar 

  2. Valdes, A. M. et al. Obesity, cigarette smoking, and telomere length in women. Lancet 366, 662–420 (2005).

    Article  CAS  Google Scholar 

  3. Fyhrquist, F., Saijonmaa, O. & Strandberg, T. The roles of senescence and telomere shortening in cardiovascular disease. Nat. Rev. Cardiol. 10, 274–283 (2013).

    Article  CAS  Google Scholar 

  4. Révész, D., Milaneschi, Y., Verhoeven, J. E. & Penninx, B. W. Telomere length as a marker of cellular ageing is associated with prevalence and progression of metabolic syndrome. J. Clin. Endocrinol. Metab. http://dx.doi.org/10.1210/jc.2014-1851.

  5. Haycock, P. C et al. Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis. BMJ 349, g4227 (2014).

    Article  Google Scholar 

  6. Codd, V. et al. Identification of seven loci affecting mean telomere length and their association with disease. Nat. Genet. 45, 422–427 (2013).

    Article  CAS  Google Scholar 

  7. Vasan, R. S. et al. Association of leukocyte telomere length with echocardiographic left ventricular mass: the Framingham heart study. Circulation 120, 1195–1202 (2009).

    Article  Google Scholar 

  8. Kuznetsova, T. et al. Association between left ventricular mass and telomere length in a population study. Am. J. Epidemiol. 172, 440–450 (2010).

    Article  Google Scholar 

  9. Nilsson, P. M., Tufvesson, H., Leosdottir, M. & Melander, O. Telomeres and cardiovascular disease risk: an update. Transl. Res. 162, 371–380 (2013).

    Article  CAS  Google Scholar 

  10. Ornish, D. et al. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol. 14, 1112–1120 (2013).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

P.M.N. has received grant support the Swedish Research Council for a project on early vascular ageing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter M. Nilsson.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nilsson, P. Telomere length and the metabolic syndrome—a causal link?. Nat Rev Endocrinol 10, 706–707 (2014). https://doi.org/10.1038/nrendo.2014.182

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2014.182

  • Springer Nature Limited

This article is cited by

Navigation